Cerebrospinal fluid F <sub>2</sub> -isoprostanes are elevated in Huntington’s disease

Thomas J. Montine, M. F. Beal, David Robertson, Merit Cudkowicz, Italo Biaggioni, Hilary O‘Donnell, William E. Zackert, L. Jackson Roberts, Jason D. Morrow

Neurology · 1999 · 102 citations · 5 references

Concepts

Abstract

Numerous investigations using a variety of experimental model systems have suggested that oxidative stress in the context of impaired energy metabolism may be an important element in the pathogenesis of Huntington’s disease (HD).1 To test further the hypothesis that oxidative damage may contribute to the progression of HD, we measured a quantitative and specific marker of lipid peroxidation, F2-isoprostanes (F2-IsoP), in CSF from HD patients early in the course of disease. This was then compared with control subjects and patients with another degenerative disease of the basal ganglia that also has been associated with increased oxidative damage: multiple system atrophy—striatonigral degeneration type (MSA-P).2 Following informed consent, CSF was aspirated from the lumbar cistern, and 1 to 2 mL were immediately frozen at −80 °C and later used for F2-IsoP quantification as described.3 All CSF had protein and glucose concentrations as well as cell counts within normal ranges. Statistical comparisons were made with GraphPad Prism 2.0 software (San Diego, CA). Control subjects (n = 23) were hospitalized patients who underwent diagnostic evaluation …

References

5